Few mammalian genes undergo allele-specific methylation - imprinting - that limits their expression to only one parental allele. Imprinting abnormalities lead to only a handful of human diseases, including pseudohypoparathyroidism type Ib (PHP-Ib), which is caused either by maternally inherited microdeletions within or up-stream of GNAS (autosomal dominant PHP-Ib;AD-PHP-Ib), by paternal uniparental isodisomy involving the GNAS locus on chromosome 20q (patUPD20q), or by an as-of-yet undefined genetic defect unrelated to GNAS. Common to these different PHP-Ib variants is a loss of all or some maternal GNAS methylation imprints, which impairs Gs? expression from the maternal allele, leading in proximal renal tubules (and few other tissues) to deficiency of Gs?, the signaling protein down-stream of the PTH-receptor (PTHR1). This results in hypocalcemia, hyperphosphatemia, and insufficient 1,25(OH)2 vitamin D (1,25D) production despite elevated PTH levels, but no increase in the levels of fibroblast growth factor 23 (FGF23), a recently discovered phosphaturic hormone. Many aspects of the defective regulation of calcium-phosphate homeostasis in PHP-Ib remain undefined, particularly the role of FGF23, which is produced by osteocytes, possibly in response to PTH. However, it remains uncertain whether Gs?-signaling is imprinted in these cells or why FGF23 does not prevent the development of hyperphosphatemia. Gs? imprinting may also occur in other tissues, including thyroid, pituitary, bone, and brown adipocytes, but it is difficult to explore these PHP-Ib aspects in patients. We therefore generated mice carrying a GNAS deletion (?Nesp55) identified in some AD-PHP-Ib patients. Mice with paternal deletion (?Nesp55p) are healthy and fertile, while maternal inheritance (?Nesp55m) leads to the same GNAS methylation changes as in AD-PHP-Ib and consequently to PTH-resistant abnormalities in mineral ion homeostasis. Surprisingly, the ?Nesp55m animals die by day P5, strongly indicating that Gs? expression from the maternal allele alone occurs not only in the proximal renal tubules, but also in other tissues. By crossing ?Nesp55p females with ?XLm males (both are healthy) to generate ?XLp/?Nesp55m offspring, we developed a viable model of AD-PHP-Ib. This model will help define the intricate interplay between PTH, FGF23, 1,25D, and possibly other hormones (Aim 1). We will furthermore determine whether imprinted Gs? expression occurs in additional tissues, such as pituitary, thyroid, and possibly some bone cells, and how Gs? expression from the non-methylated GNAS allele is silenced through cis- and/or transacting mechanisms (Aim 2). The results of the proposed studies will likely to improve diagnosis and treatment of PHP patients, and will have important implications for the treatment of other imprinting disorders and for common diseases such as osteoporosis and chronic kidney disease.

Public Health Relevance

Several rare human diseases are characterized by low blood calcium and elevated blood phosphorus and parathyroid hormone levels. Some of these diseases are caused by defects in the GNAS gene;other disease variants have not yet been defined and are the focus of this application. Changes similar to those in humans can also be observed in mice carrying GNAS mutations thus allowing studies to determine the mechanisms leading to abnormal calcium and phosphate regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK046718-21
Application #
8626382
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Malozowski, Saul N
Project Start
1993-05-01
Project End
2017-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
21
Fiscal Year
2014
Total Cost
$425,124
Indirect Cost
$175,124
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Molinaro, Angelo; Tiosano, Dov; Takatani, Rieko et al. (2015) TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib). J Bone Miner Res 30:906-12
Nistala, Harikiran; Mäkitie, Outi; Jüppner, Harald (2014) Caffey disease: new perspectives on old questions. Bone 60:246-51
Dasgupta, Debayan; Wee, Mark J; Reyes, Monica et al. (2014) Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis. J Am Soc Nephrol 25:2366-75
Mannstadt, Michael; Harris, Mark; Bravenboer, Bert et al. (2013) Germline mutations affecting G*11 in hypoparathyroidism. N Engl J Med 368:2532-4
Richard, Nicolas; Molin, Arnaud; Coudray, Nadia et al. (2013) Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XL*s in fetal development. J Clin Endocrinol Metab 98:E1549-56
Frohlich, Leopold F; Mrakovcic, Maria; Steinborn, Ralf et al. (2010) Targeted deletion of the Nesp55 DMR defines another Gnas imprinting control region and provides a mouse model of autosomal dominant PHP-Ib. Proc Natl Acad Sci U S A 107:9275-80
Frohlich, Leopold F; Bastepe, Murat; Ozturk, Defne et al. (2007) Lack of Gnas epigenetic changes and pseudohypoparathyroidism type Ib in mice with targeted disruption of syntaxin-16. Endocrinology 148:2925-35
Bergwitz, Clemens; Roslin, Nicole M; Tieder, Martin et al. (2006) SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 78:179-92
Bastepe, Murat; Weinstein, Lee S; Ogata, Naoshi et al. (2004) Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc Natl Acad Sci U S A 101:14794-9
Goodman, William G; Juppner, Harald; Salusky, Isidro B et al. (2003) Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int 63:1-11

Showing the most recent 10 out of 12 publications